Type 1 interferon gene transfer enhances host defense against pulmonary Streptococcus pneumoniae infection via activating innate leukocytes

Molecular Therapy Methods and Clinical Development

Volumn 1, Issue , 2014, Pages 5-

  Damjanovic, Daniela ^a,b   Khera, Amandeep ^a,b   Medina, Maria Fe ^a,b   Ennis, Jane ^c   Turner, Jeffrey D ^c   Gauldie, Jack ^a,b   Xing, Zhou ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c Defyrus Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84944450031     PISSN: None     EISSN: 23290501     Source Type: Journal    
DOI: 10.1038/mtm.2014.5     Document Type: Article

References (28)

1. (2005). Notifiable Diseases On-Line. Public Health Agency of Canada. http://dsol-smed. phac-aspc.gc.ca/dsol-smed/ndis/index-eng.php.
2. Kadioglu, A, Weiser, JN, Paton, JC and Andrew, PW (2008). The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 6: 288-301.
3. (2001). Respiratory Disease in Canada. Canadian Institute for Health Information Canadian Lung Association, Health Canada, Statistics Canada. https://secure.cihi.ca/free-products/RespiratoryComplete.pdf.
4. (2011). Pneumococcal Disease, Invasive (IPD) Alberta Health and Wellness. Public Health Notifiable Disease Management Guidelines Government of Alberta. www.health. alberta.ca/documents/Guidelines-Pneumococcal-Disease-Invasive-IPD-2011.pdf.
5. Le Saux, N and Robinson, J (2011). Pneumonia in healthy Canadian children and youth: Practice points for management. Paediatr Child Health 16: 417-424.
6. O'Brien, KL, Wolfson, LJ, Watt, J P, Henkle, E, Deloria-Knoll, M, McCall, N et al.; Hib and Pneumococcal Global Burden of Disease Study Team. (2009). Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374: 893-902.
7. Damjanovic, D, Lai, R, Jeyanathan, M, Hogaboam, CM and Xing, Z (2013). Marked improvement of severe lung immunopathology by influenza-associated pneumococcal superinfection requires the control of both bacterial replication and host immune responses. Am J Pathol 183: 868-880.
8. (2010). Update on Pediatric Invasive Pneumococcal Disease and Recommended Use of Conjugate Pneumococcal Vaccines. vol. 36. National Advisory Committee on Immunization (NACI) Public Health Agency of Canada.
9. Chavanet, P (2012). Pneumococcus infections: is the burden still as heavy? Med Mal Infect 42: 149-153.
10. Kadioglu, A and Andrew, PW (2004). The innate immune response to pneumococcal lung infection: the untold story. Trends Immunol 25: 143-149.
11. Decker, T, Müller, M and Stockinger, S (2005). The yin and yang of type I interferon activity in bacterial infection. Nat Rev Immunol 5: 675-687.
12. Parker, D and Prince, A (2011). Type I interferon response to extracellular bacteria in the airway epithelium. Trends Immunol 32: 582-588.
13. Richardson, JS, Wong, G, Pillet, S, Schindle, S, Ennis, J, Turner, J et al. (2011). Evaluation of different strategies for post-exposure treatment of ebola virus infection in rodents. J Bioterror Biodef S1: 007.
14. Julander, JG, Ennis, J, Turner, J and Morrey, JD (2011). Treatment of yellow fever virus with an adenovirus-vectored interferon, DEF201, in a hamster model. Antimicrob Agents Chemother 55: 2067-2073.
15. Gowen, BB, Ennis, J, Russell, A, Sefing, EJ, Wong, MH and Turner, J (2011). Use of recombinant adenovirus vectored consensus IFN-a to avert severe arenavirus infection. PLoS ONE 6: e26072.
16. Gowen, BB, Ennis, J, Sefing, EJ, Wong, MH, Jung, KH and Turner, JD (2012). Extended protection against phlebovirus infection conferred by recombinant adenovirus expressing consensus inter feron (DEF201). Antimicrob Agents Chemother 56: 4168-4174.
17. Kumaki, Y, Ennis, J, Rahbar, R, Turner, JD, Wandersee, MK, Smith, AJ et al. (2011). Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model. Antiviral Res 89: 75-82.
18. Wu, JQ, Barabé, ND, Huang, YM, Rayner, GA, Christopher, ME and Schmaltz, FL (2007). Pre-and post-exposure protection against Western equine encephalitis virus after single inoculation with adenovirus vector expressing interferon alpha. Virology 369: 206-213.
19. O'Brien, L, Perkins, S, Williams, A, Eastaugh, L, Phelps, A, Wu, J et al. (2009). Alpha interferon as an adenovirus-vectored vaccine adjuvant and antiviral in Venezuelan equine encephalitis virus infection. J Gen Virol 90(Pt 4): 874-882.
20. Smee, DF, Wong, MH, Russell, A, Ennis, J and Turner, JD (2011). Therapy and long-term prophylaxis of vaccinia virus respiratory infections in mice with an adenovirus-vectored interferon alpha (mDEF201). PLoS ONE 6: e26330.
21. Weigent, DA, Huff, TL, Peterson, JW, Stanton, GJ and Baron, S (1986). Role of interferon in streptococcal infection in the mouse. Microb Pathog 1: 399-407.
22. Elhaik-Goldman, S, Kafka, D, Yossef, R, Hadad, U, Elkabets, M, Vallon-Eberhard, A et al. (2011). The natural cytotoxicity receptor 1 contribution to early clearance of Streptococcus pneumoniae and to natural killer-macrophage cross talk. PLoS ONE 6: e23472.
23. Mancuso, G, Midiri, A, Biondo, C, Beninati, C, Zummo, S, Galbo, R et al. (2007). Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. J Immunol 178: 3126-3133.
24. Parker, D, Martin, FJ, Soong, G, Harfenist, BS, Aguilar, JL, Ratner, AJ et al. (2011). Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. MBio 2: e00016-e00011.
25. Small, CL, McCormick, S, Gill, N, Kugathasan, K, Santosuosso, M, Donaldson, N et al. (2008). NK cells play a critical protective role in host defense against acute extracellular Staphylococcus aureus bacterial infection in the lung. J Immunol 180: 5558-5568.
26. Lei, XF, Ohkawara, Y, Stämpfli, MR, Gauldie, J, Croitoru, K, Jordana, M et al. (1998). Compartmentalized transgene expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) in mouse lung enhances allergic airways inflammation. Clin Exp Immunol 113: 157-165.
27. Damjanovic, D, Divangahi, M, Kugathasan, K, Small, CL, Zganiacz, A, Brown, EG et al. (2011). Negative regulation of lung inflammation and immunopathology by TNF-a during acute influenza infection. Am J Pathol 179: 2963-2976.
28. Small, CL, Shaler, CR, McCormick, S, Jeyanathan, M, Damjanovic, D, Brown, EG et al. (2010). Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung. J Immunol 184: 2048-2056.